Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Pea3 ELISA Kit (AC2464)
Cat.#: ASET-1053
Specifications
Description Human Pea3 ELISA Kit allows for the in vitro quantitative determination of human Pea3 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 46.875 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 78.125-5000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1747 Porcine Angiogenin ELISA Kit (AC3158) Quantitative inquiry ASET-1840 Human Neurexin 1 ELISA Kit (AC3251) Quantitative inquiry ASET-1942 Human SEMA3B ELISA Kit (AC3353) Quantitative inquiry ASET-1464 Human L1CAM ELISA Kit (AC2875) Quantitative inquiry ASET-2306 Human Syndecan 4 ELISA Kit (AC3717) Quantitative inquiry ASET-1413 Rat Ferritin Heavy Chain ELISA Kit (AC2824) Quantitative inquiry ASET-1510 Rat Semaphorin 7a ELISA Kit (AC2921) Quantitative inquiry ASET-1816 Mouse Drebrin ELISA Kit (AC3227) Quantitative inquiry ASET-2530 Rat Antidiuretic Hormone ELISA Kit (AC3941) Quantitative inquiry ASET-1202 Human ASTN2 ELISA Kit (AC2613) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket